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MyoDαB-crystallin, a small heat shock protein, plays an important role in muscle homeostasis. It gets up-regulated
during muscle differentiation and mice lacking αB-crystallin die prematurely with extensive muscle
wastage. We have examined the role of αB-crystallin in muscle development using C2C12 myoblasts as a
model system. Over-expression of αB-crystallin delays the muscle differentiation program signiﬁcantly.
C2C12 myoblasts over-expressing αB-crystallin (CRYAB-C2C12) display defect in cell-cycle exit upon
induction of differentiation. During differentiation, CRYAB-C2C12 cells exhibit sustained level of cyclin D1
and delay in p21 and myogenin expression as compared to C2C12 cells. We ﬁnd less accumulation of MyoD
in CRYAB-C2C12 cells than in C2C12 cells. In vivo protein stability studies reveal faster ubiquitin–
proteasome-mediated MyoD degradation in CRYAB-C2C12 cells (t1/2=1.42 h) than in C2C12 cells (t1/2=
2.37 h). Immuno-precipitation experiments showed that MyoD gets ubiquitinated at earlier time points in
CRYAB-C2C12 cells than in C2C12 cells. Our data reveal alterations in the synthesis and degradation of MyoD
in CRYAB-C2C12 cells. The level of αB-crystallin as well as its Ser-59 phosphorylated form increases with
increasing time of differentiation. Our studies show, inter alia, that αB-crystallin modulates myogenesis by
altering MyoD level and provide an interesting insight in its role in myogenesis.
Published by Elsevier B.V.1. Introduction
Muscle differentiation involves proliferation of myoblasts, fol-
lowed by cell-cycle arrest and terminal differentiation into multi-
nucleated mature muscle ﬁber [1–3]. In the proliferating condition,
myoblasts express signiﬁcant amount of αB-crystallin (small heat
shock protein), which gets induced upon differentiation [4,5]. αB-
Crystallin acts as a molecular chaperone and prevents the stress-
induced aggregation of target proteins [6–8]. Studies from our
laboratory have shown that αB-crystallin undergoes structural
alteration and displays enhanced chaperone activity at higher
temperature [9,10]. We have shown that in heat-stressed C2C12
myoblasts, αB-crystallin migrates to the nucleus, where it coloca-
lizes with lamins and SC-35 [11]. αB-crystallin seems to play an
important role in muscle homeostasis. It gets up-regulated by 10-
fold during muscle differentiation and mice lacking αB-crystallin die
prematurely with extensive muscle wastage [5,12]. A point
mutation in αB-crystallin, R120G, is known to be associated with
desmin-related myopathy, where it forms aggregates with the
desmin intermediate ﬁlaments [13,14]. All these ﬁndings clearly
suggest the importance of αB-crystallin in muscle maintenance and
differentiation.: +91 40 2716 0591.
B.V.Skeletal myogenesis is regulated by sequential and coordinated
expression of a family of muscle-speciﬁc factors–Muscle Regulatory
Factors (MRFs)–which includeMyoD,Myf5, myogenin andMRF4 [15].
MyoD and Myf5 are expressed in proliferating undifferentiated
myoblasts and are shown to be involved in the speciﬁcation of
myogenic lineage [16]. The decision to differentiate relies on the
cross-talk between MyoD and cell-cycle signaling pathways. It is
found that the over-expression of cyclin D1 results in an inhibition of
MyoD-dependent transcription and decrease in p21 expression
[17,18]. Another important parameter that governs myogenesis is
the ability of myoblasts to survive during differentiating conditions.
αB-crystallin was shown to protect myoblasts by preventing the
activation of caspase-3 during differentiation [19]. Muscle differenti-
ation has been shown to be inhibited during hypoxic condition
through accelerated degradation of MyoD protein [20]. It is important
to note that during hypoxic condition, αB-crystallin levels increase
several fold and shown to exhibits protective function [21]. These
reports clearly suggest an important role for αB-crystallin in
myogenesis. However the molecular mechanisms of its involvement
in muscle differentiation are not understood.
In the present study, we have investigated the role of αB-crystallin
in muscle differentiation using C2C12 cells, mouse myoblasts as a
model system. We ﬁnd that differentiation is delayed signiﬁcantly in
C2C12 myoblasts stably transfected with αB-crystallin. We have
probed the molecular details of this delay in differentiation: our
studies show, inter alia, that αB-crystallin modulates myogenesis by
altering cell cycle exit and MyoD levels.
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2.1. Antibodies and reagents
DMEM, Fetal Calf Serum (FCS), DMSO,MTT andmousemonoclonal
anti-Flag antibodies were purchased from Sigma Chemical Company,
USA. Cycloheximide, MG132, rabbit polyclonal anti-Ubiquitin anti-
bodies were obtained from Calbiochem, EMD Biosciences, Germany.
Propidium Iodide (PI), Alexa-488- and Cy3-conjugated secondary
antibodies were obtained from Molecular Probes, Invitrogen Corp.
Oregon, USA. Anti-GAPDH mouse monoclonal antibodies were
purchased from Chemicon International Inc., USA. Rabbit polyclonal
antibodies for αB-crystallin, phosphoserine-59-αB-crystallin and
phosphoserine-45-αB-crystallin and mouse monoclonal anti-
cyclinD1 antibodies were obtained from Stressgen Biotechnologies,
Victoria, Canada. Mouse monoclonal antibodies for MyoD were
purchased from Dako Cytomation, USA; rabbit polyclonal anti-
myogenin antibodies were from Santa Cruz, USA. Mouse monoclonal
antibodies for p21 and phospho-p38 MAPK were from BD Transduc-
tions, Pharmingen, USA. Rabbit polyclonal cleaved caspase-3 (Asp175)
antibodies were procured from Cell Signaling Technology, USA. EDTA-
free protease inhibitor cocktail (PIC) containing bestatin, pefabloc
SC, aprotinin, leupeptin, pepstatin, E-64, antipain-dihydrochloride
was procured from Roche Applied Sciences, USA; Lipofectamine-
2000 was obtained from Invitrogen, USA. HRPO-conjugated anti-
rabbit, anti-mouse secondary antibodies and Enhanced Chemilumi-
nescence (ECL) Western blot detection kit were purchased from
AmershamBiosciences, USA. Vectashieldmountingmediumcontaining
4′, 6-diamidino-2-phenylindole (DAPI) was from Vector Laboratories,
USA.
2.2. Plasmids and construction of FLAG-tagged cDNAs
cDNA of the full-length αB-crystallin was PCR-ampliﬁed using the
following primers: Forward primer—5′-GGCCGAATTCATGGACATCGC-
CATCCACCAC-3′and Reverse primer—5′-GCCCTCGAGCTATTTCTT-
GGGGGCTGCGG-3′. The PCR products were digested with EcoRI and
XhoI restriction enzyme and ligated into a modiﬁed pCDNA3 vector,
in frame with the FLAG epitope, which was inserted upstream of the
multiple cloning site. The ﬁnal positive clones were conﬁrmed by
automated DNA sequencing.
2.3. Cell culture and differentiation
C2C12, mouse skeletal myoblast cell line, was maintained at sub-
conﬂuent densities (60–70%) in DMEM supplemented with 20% fetal
calf serum (FCS), 100 units/ml of penicillin and 100 μg/ml of
streptomycin at 37 °C in a humidiﬁed atmosphere containing 5%
CO2. To induce differentiation, cells at 80–90% conﬂuencewere shifted
to DMEM supplemented with 2% horse serum, (differentiating
medium (DM)). At different time-points of differentiation, cells
were lysed in lysis buffer (50 mM Tris–HCl (pH 7.4), containing
50 mM NaCl, 5 mM EDTA, 1 mM PMSF, 50 mM NaF, 0.2 mM Na3VO4,
0.2% (v/v) NP-40 and protease inhibitor cocktail (PIC). For immuno-
ﬂourescence studies, cells were grown on cover-slips and allowed to
differentiate for different lengths of time, as indicated. Cells were
ﬁxed with 3.7% (v/v) formaldehyde after each time-point and
processed for confocal analysis. The differentiation index (DI) and
fusion index (FI) was calculated as described by Sabourin et al. [22],
using the following formulae;
DI =
No: of myogenin positive cells
No: of nuclei
FI =
No: of fused cells
No: of nuclei
The differentiation and fusion indices were calculated as per the
above formulae and represented in percentage.2.4. Stable transfections
For stable transfections, C2C12 cells were grown in six well plate
and transfected either with 1 μg pCDNA3 vector alone or with 1 μg of
pCDNA3-N FLAG-tagged-αB-crystallin plasmids using Lipofectamine
2000 reagent (Invitrogen Corp., USA). At 48 h post-transfection, the
cells were sub-cultured in medium containing geneticin (Roche
Applied Sciences, USA) and grown for a period of one month.
Subsequently, stably transfected clones of αB-crystallin were selected
in the presence of 500 μg/ml of G418 (Geneticin) (Invitrogen Corp.,
USA). Single cell clones were isolated and the ones expressing not less
than two fold higher levels of αB-crystallin (as determined by
western blot analysis using anti-Flag antibodies) were expanded and
used for our study. C2C12 cells that stably over-expressed αB-
crystallin were referred to as CRYAB-C2C12.
2.5. FACS analysis
C2C12 cells and CRYAB-C2C12 cells were allowed to differentiate
in DMEM medium containing 2% horse serum and harvested at
different time-points of differentiation. At each time point, the cells
were ﬁxed in 80% methanol, stained with propidium iodide, and cell
cycle analysis was done using Fluorescence Activated Cell Sorter, (Facs
Caliber-Becton and Dickinson USA). The values represent average of
three independent experiments and are expressed as percentage.
2.6. Immunoﬂuorescence microscopy
C2C12 cells and cells over-expressing αB-crystallin (CRYAB-
C2C12) were grown on cover slips till 80–90% conﬂuence. Subse-
quently, cells were shifted to differentiating medium (DM) and
allowed to undergo differentiation for different time periods. At each
time point, cells were washed twice with ice-cold PBS and ﬁxed with
3.7% formaldehyde. The ﬁxed cells were permeabilized with 0.05%
Triton X-100 for 8 min. After blocking with 2% BSA, cells were
incubated with antibodies speciﬁc for myogenin and αB-crystallin,
followed by incubation with Alexa-488- and Cy3-tagged secondary
antibodies respectively. The cells were mounted in Vectashield
medium containing DAPI. Confocal laser scanning microscopy was
performed on a Carl Zeiss inverted microscopy. Image analysis was
done using LSM 510 Meta software (Version 5).
2.7. SDS-PAGE and Western blot analysis
C2C12 cells and CRYAB-C2C12 cells were induced to undergo
differentiation in DM and harvested at respective time points. Cells
were lysed in ice-cold lysis buffer, sonicated and centrifuged at 20,
800 g for 10 min at 4 °C. Equal amount of protein was loaded on 12%
SDS-polyacrylamide gels. After electrophoresis, proteins were trans-
ferred to nitrocellulose membrane using a semi-dry transfer appara-
tus (Amersham Pharmacia). The membrane was blocked with 10%
(w/v) milk protein and incubated sequentially with appropriate
primary antibodies and HRPO-conjugated secondary antibodies and
was visualized using ECL kit (Amersham Biosciences, USA) according
to the manufacturer's instructions. The band intensities were
quantiﬁed by densitometry using GeneTools software (Syngene).
The ratio of band intensities of the respective blots and that of the
corresponding loading control, expressed in arbitrary units was used
for comparison. The values represent an average of a minimum of
three independent experiments.
2.8. Comparison of protein synthesis rate
C2C12 cells and CRYAB-C2C12 cells were allowed to differentiate
for 12 h and 24 h respectively and subsequently incubated with
MG132 (10 μM) to inhibit the 26S proteasomal degradation pathway.
Fig. 1.αB-crystallin alters myogenic differentiation. C2C12 cells and cells over-expressingαB-crystallin (CRYAB-C2C12) were grown to 80–90% conﬂuency in growthmedium (GM).
Subsequently, cells were allowed to differentiate in DMEM containing 2% horse serum (DM). Panel A represents the phase contrast images of differentiation stages at different time-
points at a magniﬁcation of 200X using inverted microscope, Nikon, Japan. The images obtained were further processed using Adobe Photoshop version 6.0. Panel B shows the
Differentiation index (DI) of C2C12 and CRYAB-C2C12 cells. The DI was calculated based on the total number of myogenin positive cells versus total number of nuclei. Panel C shows
the Fusion index (FI) of C2C12 and CRYAB-C2C12 cells. The FI was calculated based on the total number of fused cells (≥2 nuclei) versus total number of nuclei. The data represent
mean±S.E. of three independent experiments (⁎pb0.01; ⁎⁎pb0.05; ⁎⁎⁎pb0.002 for C2C12 versus CRYAB-C2C12 cells at respective time point).
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lysed in ice-cold cell lysis buffer and cell lysates were collected as
described above. Equal amount of proteins were subjected to SDS-
PAGE and western blot analysis was performed as described
previously followed by its densitometric analysis. The pixels for
each band were measured and normalized so that the number of
pixels at t=0was 1. The pixels of each bandwere plotted versus time.
Protein synthesis rates were compared based on the initial slope from
plots of data from 0 to 3 h.
2.9. Determination of apparent protein half-life
As described above, C2C12 cells and CRYAB-C2C12 cells were
induced to differentiate for 24 h, following which, cells were
incubated with cycloheximide (CHX, 50 μg/ml, Sigma) to inhibit
further protein synthesis. The 26S proteasomal inhibitor MG132 (N-
benzyloxycarbonyl-Leu-Leu-leucinal, 10 μM, Calbiochem) was added
along with CHX when necessary. Following incubation for 0, 0.5, 1, 2,
and 3 h, cells were lysed in lysis buffer, and equal amounts of total cell
protein were subjected to SDS-polyacrylamide gel electrophoresis.
Western blotting was performed as described above using antibodies
speciﬁc for MyoD. The pixels for each band were measured and
normalized so that the number of pixels at t=0 was 100%. Protein
degradation rate is expressed as apparent half-life (t1/2), the time for
degradation of 50% of the protein from its initial value. The log10 of the
percentage of pixels was plotted versus time, and the t1/2 was
calculated from the log10 of 50%.
2.10. Immunoprecipitation
C2C12 and CRYAB-C2C12 cells were differentiated using differen-
tiating medium (DM) for various time points. The cells lysates werelysed in 50mMTris–HCl buffer (pH 7.4) containing 50mMNaCl, 5mM
EDTA, 50 mM NaF, 1 mM PMSF, 0.2 mM Na3VO4, 0.2% NP40, 10 %
glycerol (IP buffer) at 4 °C followed bymild sonicationwith two pulses
of 10-s duration. Supernatants were collected by centrifugation at
20,800 g for 10 min. The total cell extract was incubated at 4 °C
overnight with rabbit polyclonal anti-ubiquitin antibodies. Subse-
quently, protein-G magnetic beads were added to these samples and
theywere incubated further for 4 h at 4 °C. Themagnetic bead complex
was retrieved using a magnetic separator kit (Bangs Laboratories Inc.
USA). The immunoprecipitated complexwaswashed three timeswith
ice-cold IP buffer and suspended in Laemmli buffer. The samples were
heated in a boiling water-bath for 5 min, subjected to SDS-PAGE and
processed for Western blotting using appropriate antibodies and then
detected using the ECL system (Amersham Pharmacia, USA).
3. Results
3.1. αB-crystallin alters myogenic differentiation
To delineate the possible role of αB-crystallin during myogenic
differentiation, C2C12 myoblasts and cells stably over-expressing αB-
crystallin (CRYAB-C2C12) were allowed to differentiate for different
time periods and analyzed for their ability to undergo myogenic
differentiation. Phase-contrast micrographs show fusion of myoblasts
and extensive myotube formation at 72 h of differentiation.
Surprisingly, myotube formation in CRYAB-C2C12 cells was poorer
than in C2C12 cells at similar time points (Fig. 1A). We calculated the
differentiation (DI) and fusion indices (FI) as described in Materials
and methods.
Fig. 1B shows that DI is signiﬁcantly less in CRYAB-C2C12 cells than
in C2C12 cells; at 72 h of differentiation it is ∼50% compared to ∼75%
in C2C12 cells. Similarly, the FI is ∼25% in CRYAB-C2C12 cells
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our results show that the differentiation process is severely affected in
CRYAB-C2C12 cells.
3.2. αB-crystallin maintains myoblasts in the proliferative phase
Exit from cell-cycle is critical for the completion of the muscle
differentiation program [23]. To decipher the mechanism of delay in
myogenesis, we compared the cell-cycle proﬁles of C2C12 and CRYAB-
C2C12 myoblasts. Fig. 2 shows the FACS images of myoblasts induced
to differentiate for different time points. Analysis of the FACS images
(Table 1) showed that ∼38% of the C2C12 cells were in the G1-phase
of cell cycle compared to ∼45% of CRYAB-C2C12 cells initially upon
induction of differentiation (0 h time point). Twelve hours after
induction of differentiation, C2C12 cells underwent G0/G1 arrest
(∼60%) with a concomitant and signiﬁcant decrease in the population
of G2/M pool from ∼21% before induction to ∼1.45%. Interestingly,
CRYAB-C2C12 cells showed signiﬁcantly less G0/G1 arrested cell
population (∼23%) at the 12 h time point, while the G2/M population
was comparable to that in C2C12 cells. The G0-arrested cells (subG1)
also include a pool of apoptotic cells. The relatively less percentage ofFig. 2. FACS images for cell cycle of C2C12 and CRYAB-C2C12 myoblasts as a function of time
DMEMmedium containing 2% horse serum and harvested at different time-points of differen
iodide, and cell cycle analysis was done using Fluorescence Activated Cell Sorter, (FACs Cal
C2C12 and CRYAB-C2C12 cells during differentiation.subG1 population of CRYAB-C2C12 cells compared to that of C2C12
cells at the 12-h time point of differentiation is suggestive of the
protective function of αB-crystallin. At 24 h and 48 h of differenti-
ation, the subG1 populations in C2C12 cells were higher than those in
CRYAB-C2C12 cells. Interestingly, at 96 h of differentiation, a greater
percentage of CRYAB-C2C12 cells (∼7.96%) were in G2/M phase than
in C2C12 cells (∼4.96%). This indicates that αB-crystallin maintains
the cells in the proliferative stage and delays cell-cycle arrest (Fig. 2
and Table 1).
The cell-cycle regulators, cyclin D1 and p21 function with opposite
effects—cyclin D1 induces G1/S transition, whereas p21 is involved in
inhibition of CDKs and cell-cycle arrest [24,25]. Our western blot
analysis shows a signiﬁcant expression of cyclin D1 before induction
of differentiation in C2C12 cells, following which its level decreases
sharply to 0.12 fold with concomitant increase in p21 expression to
8.3 fold at later stages of differentiation (Fig. 3A, C and D). On the
other hand, the level of cyclin D1 in CRYAB-C2C12 cells was high
initially upon differentiation (0 h time point). Interestingly, a
signiﬁcant level of cyclin D1 was sustained till 36 h of differentiation,
after which it decreased gradually (Fig. 3B and C). Moreover, there
was a delayed onset of p21 expression in CRYAB-C2C12 cells; it wasof differentiation. C2C12 cells and CRYAB-C2C12 cells were allowed to differentiate in
tiation. At each time point, the cells were ﬁxed in 80%methanol, stained with propidium
iber-Becton and Dickinson, USA). Arrows indicate the sub-G1(dead cell) population of
Table 1
Cell cycle analysis of C2C12 and CRYAB-C2C12 myoblasts induced to differentiate for
different time points. C2C12 cells and CRYAB-C2C12 cells were allowed to differentiate
in DMEMmedium containing 2% horse serum and harvested at different time-points of
differentiation. At each time point, the cells were ﬁxed in 80% methanol, stained with
propidium iodide, and cell cycle analysis was done using Fluorescence Activated Cell
Sorter, (FACs Caliber-Becton and Dickinson USA). The values represent average of three
independent experiments and are expressed as percentage.
Cell cycle stage Sub-G1 G1 G2/M
0 h C2C12 5.77±0.29 38.3±1.83 20.48±0.49
CRYAB-C2C12 3.26±0.09 45.25±1.49 23.45±1.23
12 h C2C12 59.78±0.59 14.27±0.71 1.55±0.27
CRYAB-C2C12 23.25±1.15 56.23±1.19 1.67±0.19
24 h C2C12 11.08±0.34 66.48±2.38 3.44±0.19
CRYAB-C2C12 3.51±0.39 86.72±2.21 4.44±0.16
48 h C2C12 45.97±1.61 15.88±0.83 3.03±0.21
CRYAB-C2C12 9.48±0.94 69.91±0.79 3.37±0.29
96 h C2C12 12.13±0.68 36.52±0.94 4.96±0.12
CTYAB-C2C12 3.23±0.14 44.08±0.78 7.96±1.06
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p21 increased gradually to 4.1 fold at 96 h of differentiation in CRYAB-
C2C12 cells (Fig. 3B and D). These data suggest that sustained levels of
cyclin D1 and delayed p21 expression together alter the cell-cycle
proﬁle in CRYAB-C2C12 cells.
3.3. αB-crystallin negatively regulates the expression of
myogenic markers
The results reported in the previous sections prompted us to
investigate whether delay in the cell-cycle arrest, could affect theFig. 3. Western blots showing cyclin D1 and p21 proﬁle during C2C12 and CRYAB-C2C12
differentiation medium (DM) and harvested at different time-points. Panels A and B show
crystallin (CRYAB-C2C12) cell lysates. Western blot for GAPDH, used as loading control is als
and CRYAB-C2C12 (■) cell lysates and panel D shows the graphic representation of band in
three independent experiments.expression of muscle regulatory genes. To analyze the delay in the
differentiation process, we checked the expression of differentiation
markers desmin and myogenin. Our immunostaining data for
myogenin show that myogenin-positive cells were rarely seen in
the early stages of differentiation (12 h) in CRYAB-C2C12; whereas a
signiﬁcant population of C2C12 cells expressed myogenin at this time
point. This trend was also observed at the 48 h time point (Fig. 4A).
Further, our western blot analysis shows that myogenin expression
gets induced upon differentiation and is detectable as early as 24 h of
differentiation in C2C12 cells (Fig. 4B and C). However, the expression
of myogenin was severely affected in CRYAB-C2C12 cells; signiﬁcant
increase was detected only at 72 h of differentiation (Fig. 4B and C).
Similarly, the expression of desmin was severely affected and it
appeared only after 72 h of differentiation in CRYAB-C2C12 myoblasts
compared to 48 h of differentiation in C2C12 cells (data not shown).
Together, our data show that αB-crystallin affects cell-cycle exit and
induces delay in the expression of regulatory proteins involved in the
differentiation process.
3.4. αB-crystallin alters MyoD level during muscle differentiation
During myogenesis, the expression of both myogenin and p21 is
known to be regulated by MyoD, a master regulator of differentiation
[15,26–28]. The delay in expression of muscle differentiation
regulatory proteins, myogenin and p21, in CRYAB-C2C12 cells may
be attributed to the impaired regulation of MyoD. To investigate the
possible involvement ofαB-crystallin inMyoD regulation, both C2C12
and CRYAB-C2C12 myoblasts were allowed to differentiate and MyoD
expression proﬁles were monitored during the time course of
differentiation. Our western blot analysis shows that in C2C12cells differentiation. C2C12 and CRYAB-C2C12 cells were allowed to differentiate in
western blots for cyclin D1 and p21 proﬁle from C2C12 and cells overexpressing αB-
o shown. Panel C shows the graphic representation of cyclin D1 proﬁle from C2C12 (▴)
tensities of p21 in C2C12 (▴) and CRYAB-C2C12 (■).The data represent mean±S.E. of
Fig. 4. Proﬁle of the myogenic marker, myogenin in C2C12 and CRYAB-C2C12 cells during differentiation. C2C12 and CRYAB-C2C12 cells were allowed to differentiate in DMEM
medium containing 2% horse serum and harvested at different time-points of differentiation. Panel A shows the immunostaining for myogenin in C2C12 and CRYAB-C2C12 cells at
different time periods of differentiation. Panel B shows the western blots for myogenin expression proﬁle from lysates of C2C12 cells and cells overexpressing αB-crystallin (CRYAB-
C2C12). Western blot for GAPDH, used as loading control is also shown. Panel C describes the graphic representation of band intensities of myogenin from cell lysates of C2C12 (▴)
and CRYAB-C2C12 (D) cells.
293B.N. Singh et al. / Biochimica et Biophysica Acta 1803 (2010) 288–299myoblasts, the level of MyoD increases till 24 h of differentiation and
decreases thereafter (Fig. 5A and B). On the other hand, the
expression of MyoD in CRYAB-C2C12 cells reaches a maximum at
36 h of differentiation, followed by sharp decrease in its level at later
time points (Fig. 5A and B). Thus, there is a shift in the maxima of
MyoD expression by 12 h in CRYAB-C2C12 cells compared to that in
C2C12 cells.
MyoD is a short-lived protein and gets degraded by the 26S
proteasome pathway; hence inhibiting degradation will lead to its
accumulation [29]. Since expression of MyoD in C2C12 and CRYAB-
C2C12 cells was maximal at 24 and 36 h, respectively, we have
allowed the C2C12 and CRYAB-C2C12 myoblasts to differentiate for
12 h and 24 h, respectively and then treated with the 26S proteasome
inhibitor, MG132 in order to investigate active synthesis of MyoD.
Upon treatment with MG132 (10 μM), the relative MyoD accumula-tionwas approximately 2 fold higher in C2C12myoblasts compared to
that in CRYAB-C2C12 cells (Fig. 5C and D), suggesting that the shift in
the proﬁle of MyoD during differentiation in CRYAB-C2C12 cells could
be due to its altered synthesis. We also investigated the apparent half-
life of endogenous MyoD protein in both C2C12 and CRYAB-C2C12
cells during differentiation. C2C12 and CRYAB-C2C12 myoblasts were
incubated in differentiating medium (DM) for 24 h and then treated
either with 50 μg/ml of cycloheximide (CHX), a protein synthesis
inhibitor, alone or in combination with MG132 (10 μM). Treatment of
cells with CHX alone led to decrease in MyoD level, whereas upon
treatment of the cells with both CHX and MG132, the level of MyoD
remained almost unchanged (Fig. 6A and B). In C2C12 cells, a
signiﬁcant level of MyoD was detected till 1 h of incubation with CHX
alone, whereas in CRYAB-C2C12 cells, there was a signiﬁcant decrease
in MyoD band intensity at the same time point. MyoD gets degraded
Fig. 5. MyoD proﬁles and relative MyoD synthesis in C2C12 and CRYAB-C2C12 cells during differentiation. C2C12 and CRYAB-C2C12 cells were induced to differentiate in DMEM
medium containing 2% horse serum and harvested at different time-points of differentiation. Panel A shows the western blots for the expression proﬁle of MyoD of C2C12 and cells
overexpressing αB-crystallin (CRYAB-C2C12). Western blot for GAPDH, used as loading control is also shown. Panel B shows the graphic representation of the normalized band
intensities of MyoD from C2C12 (▴) and CRYAB-C2C12 (■) cells during differentiation. Panels C and D show the relative MyoD accumulation in C2C12 and CRYAB-C2C12 cells. For
determining the apparent protein synthesis rate, C2C12 and CRYAB-C2C12 myoblasts were allowed to differentiate for 12 h and 24 h respectively. Subsequently, cells were treated
with MG132 for 0, 0.5, 1, 2, 3 h, harvested and were evaluated for MyoD. Panel C shows the western blot for the accumulation of MyoD protein. Panel D describes the relative rate of
synthesis of MyoD from C2C12 (▴) and CRYAB-C2C12 (■) cell lysates. The pixels for each band were measured and normalized so that the number of pixels at t=0was 1. The pixels
of each band were plotted versus time. The data represent mean±S.E. of three independent experiments.
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Interestingly, in CRYAB-C2C12 cells, the degradation of MyoD was
signiﬁcantly accelerated with apparent t1/2 being 1.42 h (Fig. 6D).
Upon treating the cells with CHX and MG132 together, the MyoD
protein level stabilized, indicating that the ubiquitin–proteasome
pathway is responsible for the accelerated MyoD degradation (Fig.
6A–D).
To further elucidate the mechanism of the accelerated degradation
of MyoD in CRYAB-C2C12 cells, we performed immuno-precipitation
experiments using Ub-antibody at different time points after
induction of differentiation. Our immunoblot analysis of the
immuno-precipitated complex shows MyoD protein band in both
C2C12 as well as in CRYAB-C2C12 cells. The immuno-precipitated
complex consists of MyoD of higher molecular weight compared to
normal MyoD (40 kDa), indicating that the immuno-precipitated
complex contains ubiquitinated MyoD protein. Our results show that
in C2C12 cells, no ubiquitinated band of MyoD was detected at early
hours of differentiation (0 h and 12 h). TheMyoD bandwas detectable
at 36 h of differentiation, which increased at later time points and
could be prominently visualized at 60 h of differentiation (Fig. 6E).
Interestingly, in CRYAB-C2C12 cells, the ubiquitinated MyoD band
was detected at as early as 12 h of differentiation, followed by its
gradual increase till 48 h of differentiation. After 60 h of differenti-
ation, a signiﬁcant reduction in the levels of ubiquitinated MyoD was
observed in CRYAB-C2C12 cells (Fig. 6E). We also compared the
apparent half-life of αB-crystallin during differentiation, and it seems
to be highly stable in both C2C12 cells as well as in CRYAB-C2C12 cells
(Fig. 7). Thus our data indicate that in CRYAB-C2C12 cells, ubiquiti-nylation of MyoD, and hence the ubiquitin–proteasome-mediated
degradation, is faster. Taken together, our data show that over
expression of αB-crystallin leads to decreased synthesis and en-
hanced proteasomal degradation of MyoD.
3.5. Muscle differentiation induces αB-crystallin up-regulation and
its phosphorylation
Phosphorylation of αB-crystallin plays an important role in its
localization, interaction with other proteins and modulation of its
activity [30–33]. αB-crystallin has been shown to undergo phosphor-
ylation at Ser-59 and Ser-45 residues under stress conditions such as
hyperthermia and oxidative stress, by p38-MAP kinase and p44-MAP
kinase respectively [34,35]. In order to study the effect of muscle
differentiation on the expression of αB-crystallin and its phosphor-
ylation, C2C12 and CRYAB-C2C12 cells were allowed to differentiate
for different time points and cell lysates were probed with speciﬁc
antibodies. In agreement with an earlier report [5] our western blot
analysis shows a gradual increase in the level of αB-crystallin in both
C2C12 and CRYAB-C2C12 cells upon differentiation (Fig. 8A).
Using antibodies speciﬁc for Ser-59-phosphorylated αB-crystallin,
we observed that the level of Ser-59-phosphorylated αB-crystallin
increases gradually with increasing time of differentiation in both
C2C12 and CRYAB-C2C12 cells (Fig. 8A). Since p38-MAPK is known to
phosphorylate Ser-59 residue in αB-crystallin, we investigated the
presence of activated form of p38-MAP kinase (phospho-p38-MAPK)
during the differentiation process. Our western blot data show that
the level of p-p38 MAPK increases with increasing time of
Fig. 6. Apparent half-life and extent of ubiquitination of endogenous MyoD in C2C12 and CRYAB-C2C12 cells during differentiation. C2C12 and CRYAB-C2C12 cells were induced for
differentiation till 24 h of time, followed by treatment with CHX or CHX plus MG132. Cells were harvested, lysed at 0, 0.5, 1, 2, and 3 h and western blot for MyoD protein (Panels A
and B). An equal volume of each lysate was loaded onto the gel. The pixels for each band were measured and normalized so that the number of pixels at t=0was 100%. The log10 of
the percentage of pixels was plotted versus time, and the t1/2 was calculated from the log10 of 50% (Panels C and D). For ubiquitination studies, C2C12 and CRYAB-C2C12 myoblasts
were allowed to differentiate in differentiating medium (DM) for different length of time. Total cell extract was immunoprecipitated using rabbit polyclonal anti-Ubiquitin
antibodies at 4 °C for 8 h and immunoblotted with monoclonal antibodies speciﬁc for MyoD protein (Panel E).
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increase in the expression or activation of p38-MAPK during the
differentiation process seems to be essential, as inhibition of its
activity using speciﬁc inhibitors leads to abrogation of the myogenesis
process [36]. Taken together, our data show that the expression ofαB-
crystallin as well as its phosphorylation at Ser-59 position increases
during muscle differentiation (Fig. 8) which may be critical for the
process of differentiation of myoblasts.
Further, we performed immunostaining to analyze the localization
of αB-crystallin by confocal microscopy in C2C12 and CRYAB-C2C12
cells during the differentiation process. In myoblasts, αB-crystallin is
predominantly localized in the cytoplasm with some staining in the
nucleus in both C2C12 and CRYAB-C2C12 myoblasts (Fig. 9A).
Importantly, over-expression of αB-crystallin does not result in
altered localization in CRYAB-C2C12 cells. The ﬂuorescence intensity
of αB-crystallin staining gradually increased with increasing time of
differentiation, indicating its enhanced expression during the differ-
entiation process. The nuclei of the differentiated myotubes were
devoid of speckle-like staining; αB-crystallin remained localizedexclusively to the cytoplasm of the myotubes (Fig. 9A). Importantly,
confocal images of basal optical sections show that αB-crystallin
exhibits ﬁber-like morphology in the myotubes of C2C12 as well as
CRYAB-C2C12 cells (Fig. 9B), but not in myoblasts, suggesting a
speciﬁc role for αB-crystallin at later stages of differentiation. Since
extensive reorganization of cytoskeleton takes place during the
differentiation process, αB-crystallin may be speculated to have a
role in modulation of cytoskeleton and/or associated proteins.
3.6. αB-crystallin inhibits caspase-3 activation during differentiation
Caspase-3 activation seems to be essential for skeletal muscle
differentiation; inhibition of muscle differentiation was found in mice
lacking caspase-3 [37]. Since caspase-3 is also responsible for
apoptotic cell death during muscle differentiation [38], a proper
modulation of caspase-3 activity is essential for myogenic differen-
tiation. We examined the effect of αB-crystallin on the activation of
caspase-3 during the differentiation of C2C12 and CRYAB-C2C12
myoblasts. Our western blot analysis using antibodies speciﬁc for
Fig. 7. Half-life of αB-crystallin in C2C12 and CRYAB-C2C12 cells during differentiation. C2C12 and CRYAB-C2C12 cells were induced for differentiation till 24 h of time. Further, cells
were treated with CHX alone or with CHX and MG132. Cells were lysed at 0, 0.5, 1, 2, and 3 h and western blot was performed for αB-crystallin (Panels A and B). The pixels for each
band were measured and normalized so that the number of pixels at t=0 was 100%. The log10 of the percentage of pixels was plotted versus time, and the t1/2 was calculated from
the log10 of 50% (Panels C and D).
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cleaved to p17/p12 (active caspase-3) in the C2C12 cells at 24 h and
48 h time points. Importantly, at later time points (72 h and 96 h), weFig. 8.Western blots showing p-p38-MAPK, αB-crystallin and phospho-Ser-59-αB-crystallin
cells were allowed to differentiate in DM and harvested at different time-points of differentia
proﬁle. Panel B shows the proﬁle of phospho-p38MAPK from C2C12 and cells over-expressin
is also shown.could only detect a very faint band of active-caspase-3 (Fig. 10).
Interestingly, in CRYAB-C2C12 cells, active caspase-3 was barely
detectable at 72 h and was clearly visible at 96 h of differentiationproﬁle during C2C12 and CRYAB-C2C12 cells differentiation. C2C12 and CRYAB-C2C12
tion. Panel A shows the western blot ofαB-crystallin and phospho-Ser-59-αB-crystallin
gαB-crystallin (CRYAB-C2C12) lysates. Western blot for GAPDH, used as loading control
Fig. 9. Immunolocalization ofαB-crystallin during differentiation. C2C12 and CRYAB-C2C12myoblasts, grown on coverslips were induced to differentiate for different length of time.
The cells were ﬁxed in 3.7% (v/v) formaldehyde and immunostained using αB-crystallin-speciﬁc antibodies. Panel A represents the confocal images for αB-crystallin in C2C12 and
CRYAB-C2C12 with optical sections of 0.3 μm. Panel B shows the localization of αB-crystallin at the basal region. The ﬁber-like morphology was apparent at the basal region. The
nuclei were counterstained with DAPI. The scale bar represents 10 μm.
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activity by preventing the maturation of pro-caspase-3 during muscle
differentiation.
4. Discussion
Small heat shock proteins (sHSPs) are constitutively expressed in
several tissues including skeletal muscles, where they have been
shown to be involved in stress tolerance and muscle maintenance
[39–41]. Skeletal muscle appears to be unique tissue where as many
as six out of ten mammalian sHSPs are found [42], three of which are
stress-inducible [41,43]. Skeletal muscles are constantly subjected to
stress or injury and require repair and regeneration to maintain tissue
homeostasis. It is plausible that these sHSPs may help in stress
tolerance and maintenance of tissue homeostasis. Muscle mainte-
nance involves activation of a sub-set of cells, satellite cells, to
proliferate followed by their exit from the cell cycle to engage in the
myogenic differentiation program [44].
Myogenic differentiation is under the strict control of myogenic
transcription factors such as MyoD, Myf5, myogenin and MRF4 in co-
ordination with a second class of transcription factors includingMEF2A-2D [15,23,44]. Mice lacking MyoD develop normally but are
severely impaired in their ability to regenerate muscle after tissue
injury [45]. MyoD is found to be a master regulator of muscle
differentiation and is involved in the determination of the muscle cell
lineage [26]. The promoter of sHSPs has been shown to contain at least
one MyoD/myogenin binding site. Sugiyama et al. [42] have shown
that sHSPs form two different complexes during muscle differentia-
tion, implying their importance in muscle development. Of these
sHSPs, αB-crystallin seems to play an essential role in muscle
differentiation and its maintenance. During muscle differentiation,
the level of αB-crystallin goes up 10-fold, and mice lacking αB-
crystallin have lower muscle mass [5,12]. A point mutation in αB-
crystallin, R120G, has been found to be associated with desmin-
related myopathies, suggesting its importance in muscle tissue
homeostasis [13,14]. Despite these reports, the exact function of αB-
crystallin during muscle development is not yet clearly understood.
In this study, we have probed the role of αB-crystallin and
sequential events in the muscle differentiation process. We have
demonstrated that αB-crystallin modulates MyoD activity by the
combined effect of its reduced synthesis and increased degradation,
thus delaying muscle differentiation. We ﬁnd that the myotube
Fig. 10.Western blots showing cleaved caspase-3 during C2C12 and CRYAB-C2C12 cells
differentiation. C2C12 and CRYAB-C2C12 cells were allowed to differentiate in DM and
harvested at different time-points of differentiation. Western blot analysis for cleaved
caspase-3 was performed using C2C12 and CRYAB-C2C12 cell lysates. Western blot for
GAPDH, used as loading control is also shown.
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(CRYAB-C2C12 cells) (Fig. 1A–C). Terminal cell cycle arrest is
coupled to muscle differentiation and is required for the activation
of muscle-speciﬁc gene expression [3,17,23]. An analysis of cell-cycle
proﬁle shows that CRYAB-C2C12 cells were more proliferative; the
level of cell cycle marker cyclin D1 was sustained for longer period
and expression of p21 was delayed (Fig. 3). Our western blot analysis
shows that the maxima of MyoD expression gets shifted by about
12 h in CRYAB-C2C12 cells compared to C2C12 cells (Fig. 5A).
Interestingly, we observed reduced accumulation of MyoD (corre-
lated with the relative rates of protein synthesis in vivo) in CRYAB-
C2C12 cells within 1 h of incubation with MG132 (Fig. 5C). It is
important to note that activated NF-κB has been shown to induce
MyoD mRNA loss [46], therefore it may be speculated that the
reduced accumulation of MyoD is due to the activation of NF-κB
through αB-crystallin. Further, we ﬁnd that the apparent half-life of
MyoD is reduced (t1/2=1.42 h) in CRYAB-C2C12 cells compared to
C2C12 cells (t1/2=2.37 h) (Fig. 6A–D). Our immuno-precipitation
experiments show the enhanced ubiquitination in CRYAB-C2C12
cells, which possibly leads to accelerated degradation of MyoD in
CRYAB-C2C12 cells compared to that in C2C12 cells (Fig. 6E).
Interestingly, we have consistently observed a transient decrease in
the level of ubiquitinated-MyoD at the 24 h time-point in CRYAB-
C2C12 cells. While the reason for this transient decrease is not clear,
we speculate that it may be due to the reduced synthesis of MyoD,
which we have observed (Fig. 5). Notably, αB-crystallin has been
shown to be a part of the FBX4-Ub complex and promotes FBX4-
dependent ubiquitination in a Ser-45 and Ser-19 phosphorylationFig. 11. Model depicting the involvement of αB-crystallin during myogenesis. During my
MAPKAP-2/3 leads to phosphorylation of αB-crystallin at Ser-59 position. αB-crystallin is i
degradation. αB-crystallin activates NF-κB in a phosphorylation-dependent manner, which
arrow). The higher and sustained level of cyclin D1 and reduced level of p21 leads to increas
myogenic differentiation.dependent manner [32,47]. αB-crystallin is known to induce
ubiquitination of cyclin D1 in cancerous tissue; however, its
phosphorylation dependency is not yet investigated [48]. During
the differentiation process, we show that αB-crystallin gets
phosphorylated at Ser-59 residue (Fig. 8A). p38-MAP kinase is
known to be involved in Ser-59 phosphorylation. Whether this
preferential phosphorylation plays a role in MyoD ubiquitination is
not clear at present. We have observed that the level of p38-MAP
kinase increases gradually with induction of differentiation (Fig. 8B).
This observation is consistent with the earlier report of activation of
p38-MAP kinase during the differentiation process [49]. Our
immuno-staining data show that during differentiation, αB-crystallin
remains exclusively in the cytoplasm of myotubes with no speckle-
like staining in the nucleus as observed in myoblasts (Fig. 9A).
Earlier studies from our laboratory demonstrated that αB-crystallin
co-localizes with the lamin A/C network in heat-stressed myoblasts
but not in myotubes [11]. Importantly, the basal optical sections
show that αB-crystallin exhibits ﬁber-like morphology in myotubes
(Fig. 9B), indicating that it may have a role in modulating
cytoskeleton dynamics. We have demonstrated the role of αB-
crystallin in modulating actin dynamics in cardiac muscle cells,
where it performs an actin-stabilizing function [50].
During the differentiation process, one of the critical factors is the
ability to survive under differentiating conditions. αB-crystallin has
been shown to negatively regulate apoptosis by inhibiting caspase-3
activation during differentiation [19]. Interestingly, caspase-3 activity
is required for the skeletal muscle differentiation, as it is involved in
the cleavage of regulatory proteins important for myogenesis [37].
Thus critical balance of activation and inhibition of caspase-3 appears
to be important. We ﬁnd that αB-crystallin prevents the activation of
caspase-3 (Fig. 10), which may contribute towards the delay in the
muscle differentiation process. Based on our observations, we propose
a scheme that summarizes the role of αB-crystallin in muscle
differentiation (Fig. 11). The data presented in this report suggest
that αB-crystallin delays myogenic differentiation through the
reduced synthesis and activated degradation of MyoD protein. Our
unpublished data suggest that αB-crystallin can activate NF-κB
signaling pathway in a phosphorylation-dependent manner. Activat-
ed NF-κB has been shown to reduce MyoD mRNA [46] and inhibit
myogenesis by augmenting the expression of growth stimulatory
molecules such as cyclin D1 [18]. The higher and sustained level of
cyclin D1 and reduced level of p21 leads to increased cell proliferation.
Increased proliferation and/or degradation of MyoD are antagonist to
myogenic differentiation (Fig. 11). Taken together, our data suggest
that αB-crystallin is essential for muscle differentiation and regula-
tion of αB-crystallin is very important for proper myogenesis.ogenesis, p38-MAPkinase gets activated, which activates MAPKAP-2/3. Activation of
nvolved in modulating MyoD activity by reduced synthesis and enhanced proteasomal
in turn activates cyclin D1 transcription and reduces MyoD mRNA (shown by broken
ed cell proliferation. Sustained cell proliferation and increased MyoD degradation delay
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